(Q50681290)

17 March 2018

title

Costs, quality of life and disease severity in multiple sclerosis: a cross-sectional study in Sweden. (English)

1 reference

17 March 2018

0 references

0 references

1 reference

S Fredrikson

2

0 references

author name string

F Henriksson

series ordinal

1

1 reference

17 March 2018

T Masterman

series ordinal

3

1 reference

17 March 2018

B Jönsson

series ordinal

4

1 reference

17 March 2018

publication date

1 January 2001

1 reference

17 March 2018

European Journal of Neurology

published in

1 reference

17 March 2018

volume

8

1 reference

17 March 2018

issue

1

1 reference

17 March 2018

page(s)

27-35

1 reference

17 March 2018

EuroQol--a new facility for the measurement of health-related quality of life

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00169.X

The economic cost of multiple sclerosis in Sweden in 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00169.X

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00169.X

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00169.X

Defining the clinical course of multiple sclerosis: Results of an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00169.X

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00169.X

Interferon-beta in multiple sclerosis. Can we control its costs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00169.X

Methodology. Health-state utilities in a general population in relation to age, gender and socioeconomic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00169.X

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00169.X

10.1046/J.1468-1331.2001.00169.X

21 January 2018

Identifiers

DOI

1 reference

17 March 2018

1 reference

17 March 2018